O116 Does aspirin interfere with the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in systolic chronic heart failure?: Analysis of the EMPHASIS-HF study

Clinical Benefits

Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease

European Journal of Heart Failure ◽

10.1002/ejhf.218 ◽

2015 ◽

Vol 17 (2) ◽

pp. 224-232 ◽

Cited By ~ 54

Author(s):

Bertram Pitt ◽

Stefan D. Anker ◽

Michael Böhm ◽

Mihai Gheorghiade ◽

Lars Køber ◽

...

Keyword(s):

Heart Failure ◽

Chronic Kidney Disease ◽

Chronic Heart Failure ◽

Kidney Disease ◽

Receptor Antagonist ◽

Randomized Study ◽

Effects of mineralocorticoid receptor antagonist spironolactone on cardiac sympathetic nerve activity and prognosis in patients with chronic heart failure

International Journal of Cardiology ◽

10.1016/j.ijcard.2011.12.080 ◽

2013 ◽

Vol 167 (1) ◽

pp. 244-249 ◽

Cited By ~ 15

Author(s):

Shu Kasama ◽

Takuji Toyama ◽

Hiroyuki Sumino ◽

Hisao Kumakura ◽

Yoshiaki Takayama ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Receptor Antagonist ◽

Sympathetic Nerve ◽

Sympathetic Nerve Activity ◽

Cardiac Sympathetic Nerve ◽

Nerve Activity ◽

Cardiac Sympathetic Nerve Activity

Relationship Between Galectin-3 Levels and Mineralocorticoid Receptor Antagonist Use in Heart Failure: Analysis From HF-ACTION

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2013.11.011 ◽

2014 ◽

Vol 20 (1) ◽

pp. 38-44 ◽

Cited By ~ 21

Author(s):

Mona Fiuzat ◽

Phillip J. Schulte ◽

Michael Felker ◽

Tariq Ahmad ◽

Megan Neely ◽

...

Keyword(s):

Heart Failure ◽

Failure Analysis ◽

Receptor Antagonist ◽

Galectin 3

The importance of a higher dose of a mineralocorticoid receptor antagonist in reducing risk of reccurent hospitalization in a patient with advanced chronic heart failure - A case report

Cor et Vasa ◽

10.1016/j.crvasa.2017.08.004 ◽

2018 ◽

Vol 60 (5) ◽

pp. e527-e530 ◽

Cited By ~ 1

Author(s):

Ghada Mairgani ◽

Václav Mála ◽

Filip Málek

Keyword(s):

Heart Failure ◽

Case Report ◽

Chronic Heart Failure ◽

Receptor Antagonist ◽

ELEVATED GALECTIN-3 DOES NOT PREDICT BENEFIT FROM MINERALOCORTICOID RECEPTOR ANTAGONIST USE IN PATIENTS WITH CHRONIC HEART FAILURE DUE TO LEFT VENTRICULAR SYSTOLIC DYSFUNCTION

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(15)60970-6 ◽

2015 ◽

Vol 65 (10) ◽

pp. A970

Author(s):

Parul U. Gandhi ◽

Shweta Motiwala ◽

Arianna Belcher ◽

Hanna Gaggin ◽

Rory Weiner ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Receptor Antagonist ◽

Left Ventricular Systolic Dysfunction ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Ventricular Systolic Dysfunction ◽

Galectin 3

Faculty Opinions recommendation of Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725355266.793521191 ◽

2016 ◽

Author(s):

Jai Radhakrishnan

Keyword(s):

Heart Failure ◽

Chronic Kidney Disease ◽

Chronic Heart Failure ◽

Kidney Disease ◽

Receptor Antagonist ◽

Randomized Study ◽

Galectin-3 and mineralocorticoid receptor antagonist use in patients with chronic heart failure due to left ventricular systolic dysfunction

American Heart Journal ◽

10.1016/j.ahj.2014.12.012 ◽

2015 ◽

Vol 169 (3) ◽

pp. 404-411.e3 ◽

Cited By ~ 22

Author(s):

Parul U. Gandhi ◽

Shweta R. Motiwala ◽

Arianna M. Belcher ◽

Hanna K. Gaggin ◽

Rory B. Weiner ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Receptor Antagonist ◽

Left Ventricular Systolic Dysfunction ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Ventricular Systolic Dysfunction ◽

Galectin 3

Aspirin does not reduce the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in patients with systolic heart failure and mild symptoms: an analysis of the EMPHASIS-HF study

European Journal of Heart Failure ◽

10.1002/ejhf.485 ◽

2016 ◽

Vol 18 (9) ◽

pp. 1175-1181 ◽

Cited By ~ 9

Author(s):

Ken Lee Chin ◽

Timothy J. Collier ◽

Bertram Pitt ◽

John J.V. McMurray ◽

Karl Swedberg ◽

...

Keyword(s):

Heart Failure ◽

Receptor Antagonist ◽

Systolic Heart Failure ◽

Clinical Benefits

The use of a novel non-steroidal mineralocorticoid receptor antagonist finerenone for the treatment of chronic heart failure

Medicine ◽

10.1097/md.0000000000010254 ◽

2018 ◽

Vol 97 (16) ◽

pp. e0254 ◽

Cited By ~ 19

Author(s):

Hui Pei ◽

Wei Wang ◽

Di Zhao ◽

Lei Wang ◽

Guo-Hai Su ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Receptor Antagonist ◽

Interaction Between Mineralocorticoid Receptor Antagonist and Soluble ST2 in Heart Failure with Preserved Ejection Fraction

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2017.08.062 ◽

2017 ◽

Vol 23 (10) ◽

pp. S20

Author(s):

Akinori Sugano ◽

Yoshihiro Seo ◽

Tomoko Ishizu ◽

Masayoshi Yamamoto ◽

Yoshie Hamada ◽

...

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Receptor Antagonist ◽

Preserved Ejection Fraction ◽

Soluble St2